Colloid carcinoma of the pancreas: Review of selected pathological and clinical aspects

Pathology

Volumn 40, Issue 7, 2008, Pages 655-663

  Liszka, Łukasz ^a   Zielińska Pajak, Ewa ^a   Pajak, Jacek ^a   Gołka, Dariusz ^b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b BLACKPOOL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Colloid carcinoma; Mucinous carcinoma; Pancreas; Pancreatic cancer; Pancreatic neoplasms

Indexed keywords

MUCIN; MUCIN 2;

CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CLINICAL FEATURE; COLLOID CARCINOMA; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; LONG TERM CARE; MEDICAL DECISION MAKING; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PREOPERATIVE PERIOD; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; WORLD HEALTH ORGANIZATION;

EID: 55549143003     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020802436444     Document Type: Article

References (75)

1. Kloppel G, Hruban RH, Longnecker DS, Adler G, Kern SE, Partanen TJ. Ductal adenocarcinoma of the pancreas. In: Hamilton SR, Aaltonen LA, editors. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Digestive System. Lyon: IARC Press, 2000; 221-30.
2. Hruban RH, Pitman MB, Klimstra DS. AFIP Atlas of Tumor Pathology. Tumors of the Pancreas. 4th Series, Fascicle 6. Washington: American Registry of Pathology, Armed Forces Institute of Pathology, 2007.
3. Adsay NV, Pierson C, Sarkar F, et al. Colloid (mucinous noncystic) carcinoma of the pancreas. Am J Surg Pathol 2001; 25: 26-42.
4. Longnecker DS, Adler G, Hruban RH, Kloppel G. Intraductal papillary-mucinous neoplasms of the pancreas. In: Hamilton SR, Aaltonen LA, editors. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Digestive System, Lyon: IARC Press, 2000: 237-40.
5. Hruban RH, Takaori K, Klimstra DS, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004; 28: 977-87.
6. Adsay NV, Merati K, Nassar H, et al. Pathogenesis of colloid (pure mucinous) carcinoam of exocrine pancreas. Coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas. Am J Surg Pathol 2003; 27: 571-8.
7. Shimada K, Sakamoto Y, Sano T, Kosuge T, Hiraoka N. Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas. A clinicopathologic comparison with a common type of invasive ductal carcinoma. Pancreas 2006; 32: 281-7.
8. Fukushima N, Mukai K, Kanai Y, et al. Intraductal papillary tumors and mucinous cystic tumors of the pancreas: clinicopathologic study of 38 cases. Hum Pathol 1997; 28: 1010-7.
9. Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas. An updated experience. Ann Surg 2004; 239: 788-99.
10. Iacobuzio-Donahue CA, Klimstra DS, Adsay NV, et al. Dpc4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas. Am J Pathol 2000; 157: 755-61.
11. Adsay NV, Merati K, Basturk O, et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms. Delineation of an "intestinal" pathway of carcinogenesis in the pancreas. Am J Surg Pathol 2004; 28: 839-48.
12. Fukushima N, Mukai K, Sakamoto M, et al. Invasive carcinoma derived from intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic and immunohistochemical study of eight cases. Virchows Arch 2001; 439: 6-13.
13. Sessa F, Solcia E, Capella C, et al. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell di.erentiation and K-ras, p53 and cerbB-2 abnormalities in 26 patients. Virchows Arch 1994; 42: 357-67.
14. Luttges J, Zamboni G, Longnecker D, Kloppel G. The immunohistochemical mucin expression pattern distiguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am J Surg Pathol 2001; 25: 942-48.
15. Klimstra DS. Cystic, mucin-producing neoplasms of the pancreas: the distinguishing features of mucinous cystic neoplasms and intraductal papillary mucinous neoplasms. Semin Diagn Pathol 2005; 22: 318-29.
16. Adsay NV, Conlon KC, Zee SY, Brennan MF, Klimstar DS. Intraductal papillary-mucinous neoplasms of the pancreas. An analysis of in situ and invasive carcinomas in 28 patients. Cancer 2002; 94: 62-77.
17. Zamboni G, Kloppel G, Hruban RH, Longnecker DS, Adler G. Mucinous cystic neoplasms of the pancreas. In: Hamilton SR, Aaltonen LA, editors. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Digestive System. Lyon: IARC Press, 2000; 234-6.
18. Iacobuzio-Donahue CA, Wilentz RE, Argani P, et al. Dpc4 protein in mucinous cystic neoplasms of the pancreas. Frequent loss of expression in invasive carcinomas suggests a role in genetic progression. Am J Surg Pathol 2000; 24: 1544-8.
19. Thompson L, Becker R, Przygodzki R, Adair CF, He.ess CS. Mucinous cystic neoplasms (mucinous cystadenocarcinoma of lowgrade malignant potential) of the pancreas: a clinicopathologic study of 130 patients. Am J Surg Pathol 1999; 23: 1-16.
20. Zamboni G, Scarpa A, Bogina G, et al. Mucinous cystic tumors of the pancreas. Clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol 1999; 23: 410-22.
21. Wilentz RE, Albores-Saavedra J, Zahurak M, et al. Pathologic examination accurately predicts prognosis in mucinous cystic neoplasms of the pancreas. Am J Surg Pathol 1999: 23: 1320-7.
22. Wilentz RE, Albores-Saavedra J, Hruban RH. Mucinous cystic neoplasms of the pancreas. Semin Diagn Pathol 2000; 17: 31-42.
23. Adsay NV, Merati K, Andea A, et al. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol 2002; 15: 1087-95.
24. Suda K, Nobukaw B, Yamasaki AS, Suzukimd F, Shimizu H, Takase M. Pre-existing histological type and developmental mechanism of mucinous noncystic carcinoma of pancreas. Pathol Oncol Res 2000; 6: 125-9.
25. Luttges J, Beyser K, Pust S, Paulus A, Ruscho. J, Kloppel G. Pancreatic mucinous noncytsic (colloid) carcinomas and intraductal papillary mucinous carcinomas are usually microsatellite stable. Mod Pathol 2003; 16: 537-42.
26. Whang EE, Danial T, Dunn JC, et al. The spectrum of mucinproducing adenocarcinoma of the pancreas. Pancreas 2000; 21: 147-51.
27. Luttges J, Kloppel G. Update on the pathology and genetics of exocrine pancreatic tumors with ductal phenotype: precursor lesions and new tumor entities. Dig Dis 2001; 19: 15-23.
28. D'Angelica M, Brennan MF, Suriawinata AA, Klimstra D, Conlon KC. Intraductal papillary mucinous neoplasms of the pancreas. An analysis of clinicopathologic features and outcome. Ann Surg 2004; 239: 400-8.
29. Zen Y, Fujii T, Itatsu K, et al. Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas. Hepatology 2006; 44: 1333-43.
30. Adsay NV, Pierson C, Sarkar F, Klimstra D. Invasive mucinous colloid-type adenocarcinoma of the pancreas: a distinct clinocopathologic entity. Mod Pathol 1999; 12: 159A.
31. Hruban RH, Fukushima N. Pancreatic adenocarcinoma: update on the surgical pathology of carcinomas of ductal origin and PanINs. Mod Pathol 2007; 20: S61-70.
32. Seidel G, Zahurak M, Iacobuzio-Donahue C, et al. Almost all in.ltrating colloid carcinomas of the pancreas and periampullary region arise from in situ papillary neoplasms. A study of 39 cases. Am J Surg Pathol 2002; 26: 56-63.
33. Adsay NV. Cystic lesions of the pancreas. Mod Pathol 2007; 20: S71-93.
34. Chari ST, Yadav D, Smyrk TC, et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology 2002; 123: 1500-7.
35. Yamao K, Ohashi K, Nakamura T, et al. The prognosis of intraductalpapillary mucinous tumors of the pancreas. Hepatogastroenterology 2000; 47: 1129-34.
36. Cubilla AL, Fitzgerald PJ. Cancer of the pancreas (nonendocrine): a suggested morphologic classification. Semin Oncol 1979; 6: 285-97.
37. Chien J, Baithun SI. Morphological study of 391 cases of exocrine pancreatic tumours with special reference to the classification of exocrine pancreatic carcinoma. J Pathol 1985; 146: 17-29.
38. Loftus EV, Olivares-Pakzad BA, Batts KP, et al. Intraductal papillarymucinous tumors of the pancreas: clinicopathologic features, outcome, and nomenclature. Gastroenterology 1996; 110: 1909-18.
39. Adsay NV, Longnecker DS, Klimstra DS. Pancreatic tumors with cystic dilatation of the ducts: Intraductal papillary mucinous neoplasms and intraductal oncocytic papillary neoplasms. Semin Diagn Pathol 2000; 17: 16-30.
40. Maire F, Hammel P, Terris B, et al. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut 2002; 51:717-22.
41. Adsay NV, Conlon K, Brennan M, KIimstra D. Intraductal papillarymucinous neoplasms of the pancreas (IPMN): An analysis of in situ and invasive carcinomas associated with 23 cases. Mod Pathol 1997; 10: 143A.
42. Iacobuzio-Donahue C, Adsay NV, Yeo CJ, et al. Almost all in.ltrating colloid carcinomas of the pancreas and periampullary region arise from in situ papillary neoplasms. Mod Pathol 2001; 14: 202A.
43. Ban S, Naitoh Y, Mino-Kenudson M, et al. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types. Am J Surg Pathol 2006; 30: 1561-9.
44. Yamaguchi H, Inoue T, Eguchi T, et al. Fascin overexpression in intraductal papillary mucinous neoplasms (adenomas, borderline neoplasms, and carcinomas) of the pancreas, correlated with increased histological grade. Mod Pathol 2007; 20: 552-61.
45. Molavi D, Argani P. Distinguishing benign dissecting mucin (stromal mucin pools) from invasive mucinous carcinoma. Adv Anat Pathol 2008; 15: 1-17.
46. Raut CP, Cleary KR, Staerkel GA, et al. Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. Ann Surg Oncol 2006; 13: 582-94.
47. Nara S, Shimada K, Kosuge T, Kanai Y, Hiraoka N. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms. Am J Surg Pathol 2008; 32: 243-255.
48. Nakamura A, Horinouchi M, Goto M, et al. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: Its relationship with potential for malignancy. J Pathol 2002; 197: 201-10.
49. O'Connell JT, Shao ZM, Drori E, Basbaum CB, Barsky SH. Altered mucin expression is a field change that accompanies mucinous (colloid) breast carcinoma histogenesis. Hum Pathol 1998; 29: 1517-23.
50. Nagata K, Horinouchi M, Saitou M, et al. Mucin expression profile in pancreatic cancer and precursor lesions. J Hepatobiliary Pancreat Surg 2007; 14: 243-54.
51. Furukawa T, Kloppel G, Adsay NV, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: A consensus study. Virchows Arch 2005; 447: 794-9.
52. Wilentz RE, Seidel G, Iacobuzio-Donahue CA, Hruban RH. Colloid carcinomas of the pancreas and periampullary region. Letter to the editor. Am J Surg Pathol 2002; 26: 952-3.
53. Park SY, Lee HS, Choe G, Chung JH, Kim WH. Clinicopathological characteristics, microsatellite instability and expression of mucin core proteins and p53 in colorectal mucinous adenocarcinomas in relation to location. Virchows Arch 2006; 449: 40-7.
54. Furukawa T, Fujisaki R, Yoshida Y, et al. Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepihetlial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas. Mod Pathol 2005; 18: 1034-42.
55. Kakar S, Smyrk TC. Signet-ring cell carcinoma of the colorectum: correlations between microsatellite instability, clinicopathologic features and survival. Mod Pathol 2005; 18: 244-9.
56. Yeh MM, Tang LH, Wang S, Robert ME, Zheng W, Jain D. Inhibin expression in ovarian-type stroma in mucinous cystic neoplasms of the pancreas. Appl Immunohistochem Mol Morphol 2004; 12: 148-52.
57. Zhu MH, Hu XG, Ni CR, Zhang SM, Xi PC, Yu GZ. Mucinous noncystic (colloid) adenocarcinoma of the pancreas. (Chinese; English abstract.) Zhonghua Bing Li Xue Za Zhi 2005; 34: 389-92.
58. Ricci F, Kern SE, Hruban RH, Iacobuzio-Donahue CA. Stromal response to carcinomas of the pancreas. Cancer Biol Ther 2005; 4: 302-7.
59. Hanski C, Hofmeier M, Schmitt-Gra. A, et al. Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary. J Pathol 1997; 182: 385-91.
60. Zen Y, Sasaki M, Fujii T, et al. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct - an immunohistochemical study of 110 cases of hepatolithiasis. J Hepatol 2006; 44: 350-8.
61. Shibahara H, Tamada S, Goto M, et al. Two histopathologic categories as counterparts of pancreatic intraductal papillarymucinous neoplasms. Am J Surg Pathol 2004; 28: 327-38.
62. Chen TC, Nakamura Y, Zen Y, et al. Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology 2001; 34: 651-8.
63. Zen Y, Fujii T, Itatsu K, et al. Biliary cystic tumors with bile duct communication: a cystic variant of intraductal papillary neoplasm of the bile duct. Mod Pathol 2006; 19: 1243-54.
64. Adsay NV, Klimstra DS. Not all "mucinous carcinomas" are equal: time to rede.ne and reinvestigate the biologic signi.cance of mucin types and patterns in the GI tract. Virchows Arch 2005; 447: 111-2.
65. Devaney K, Goodman ZD, Ishak KG. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol 1994; 18: 1078-91.
66. Zhai J, Sarkar R, Ylagan L. Pancreatic mucinous lesions: a retrospective analysis with cytohistological correlation. Diagn Cytopathol 2006; 34: 724-30.
67. Hardacre JM, McGee MF, Stellato TA, Schulak JJA. An aggressive surgical approach is warranted in the management of cystic pancreatic neoplasms. Am J Surg 2007; 193: 374-9.
68. Talamini G, Zamboni G, Salvia R, et al. Intraductal papillary mucinous neoplasms and chronic pancreatitis. Pancreatology 2006; 6: 626-34.
69. Chejfec G, Rieker WJ, Jablokow VR, Gould VE. Pseudomyxoma peritonei associated with colloid carcinoma of the pancreas. Gastroenterology 1986; 90: 202-5.
70. Pitman MB, Deshpande V. Endoscopic ultrasound-guided fine needle aspiration cytology of the pancreas: a morphological and multimodal approach to the diagnosis of solid and cystic mass lesions. Cytopathology 2007; 18: 331-47.
71. Fernandez-Esparrach G, Pellise M, Sole M, et al. EUS FNA is intraductal papillary mucinous tumors of the pancreas. Hepatogastroenterology 2007; 54: 260-4.
72. Ryu JK, Woo SM, Hwang JK, et al. Cyst .uid analysis for the differential diagnosis of pancreatic cysts. Diagn Cytopathol 2004; 31: 100-5.
73. Brugge WR, Lauwers GY, Sahani D, Fernandez-del Castillo C, Warshaw AL. Cystic neoplasms of the pancreas. N Eng J Med 2004; 351: 1218-26.
74. Jass JR, O'Brien MJ, Riddell RH, Snover DC. Recommendations for the reporting of surgically resected specimens of colorectal carcinoma. Hum Pathol 2007; 38: 537-45.
75. Sohn TA, Yeo CJ, Cameron JL, Iacobuzio-Donahue CA, Hruban RH, Lillemoe KD. Intraductal papillary mucinous neoplasms of the pancreas: An increasingly recognized clinicopathologic entity. Ann Surg 2001; 234: 313-22.